Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overviewAll 13F holders of DYNFull Q2 2026 holdings

Shares (Q2 2026)
1,488,917
Value
$33.1M
% of portfolio
<0.1%
Quarters held
18
Since Q2 2021
Holdings of DYN by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,488,917$33.1M<0.1%+1,405,770+1,690.7%AddedHolders
Q1 202683,147$1.51M<0.1%−593,832−87.7%ReducedHolders
Q4 2025676,979$13.2M<0.1%−2,336,398−77.5%ReducedHolders
Q3 20253,013,377$38.1M<0.1%+2,565,570+572.9%AddedHolders
Q2 2025447,807$4.26M<0.1%+447,807NewHolders
Q1 20250$00.0%−24,501−100.0%Sold outHolders
Q4 202424,501$577.2K<0.1%+24,501NewHolders
Q3 20240$00.0%−273,567−100.0%Sold outHolders
Q2 2024273,567$9.65M<0.1%+219,862+409.4%AddedHolders
Q1 202453,705$1.52M<0.1%+53,705NewHolders
Q4 20230$00.0%−22,052−100.0%Sold outHolders
Q3 202322,052$197.6K<0.1%00.0%UnchangedHolders
Q2 202322,052$248.1K<0.1%−110,292−83.3%ReducedHolders
Q1 2023132,344$1.52M<0.1%+110,292+500.1%AddedHolders
Q4 202222,052$255.6K<0.1%−42,858−66.0%ReducedHolders
Q3 202264,910$824.0K<0.1%−284,369−81.4%ReducedHolders
Q2 2022349,279$2.40M<0.1%00.0%UnchangedHolders
Q1 2022349,279$3.37M<0.1%00.0%UnchangedHolders
Q4 2021349,279$4.15M<0.1%+327,227+1,483.9%AddedHolders
Q3 202122,052$358.0K<0.1%00.0%UnchangedHolders
Q2 202122,052$464.0K<0.1%+22,052NewHolders